2008 Outlook Good for Pharma

The Big Pharma industry is set for a strong 2008, fueled by promising pipelines and cost-cutting. The biotech sector, however, may not be that lucky.

Pharmaceutical companies with up-and-coming blockbuster drugs and multi-billion dollar restructuring plans have the winning combination to boost their earnings and their stock next year, analysts say.

This would be a good indsutry for venture capital companies to look into possibly investing in the next big pharma company or affiliate. To read more about this story, click here.